Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M005764200 on July 31, 2000

J. Biol. Chem., Vol. 275, Issue 42, 32508-32515, October 20, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/42/32508    most recent
M005764200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calvert, M. J.
Right arrow Articles by Trayer, I. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calvert, M. J.
Right arrow Articles by Trayer, I. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Importance of the Carboxyl-terminal Domain of Cardiac Troponin C in Ca2+-sensitive Muscle Regulation*

Melanie J. CalvertDagger, Douglas G. Ward, Hylary R. Trayer, and Ian P. Trayer§

From the School of Biosciences, the University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom

Received for publication, June 30, 2000


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The interactions between troponin I and troponin C are central to the Ca2+-regulated control of striated muscle. Using isothermal titration microcalorimetry we have studied the binding of human cardiac troponin C (cTnC) and its isolated domains to human cardiac troponin I (cTnI). We provide the first binding data for these proteins while they are free in solution and unmodified by reporter groups. Our data reveal that the C-terminal domain of cTnC is responsible for most of the free energy change upon cTnC·cTnI binding. Importantly, the interaction between cTnI and the C-terminal domain of cTnC is 8-fold stronger in the presence of Ca2+ than in the presence of Mg2+, suggesting that the C-terminal domain of cTnC may play a modulatory role in cardiac muscle regulation. Changes in the affinity of cTnI for cTnC and its isolated C-terminal domain in response to ionic strength support this finding, with both following similar trends. At physiological ionic strength the affinity of cTnC for cTnI changed very little in response to Ca2+, although the thermodynamic data show a clear distinction between binding in the presence of Ca2+ and in the presence of Mg2+.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cardiac and skeletal muscle contraction is regulated by the troponin complex and tropomyosin. The troponin complex consists of three proteins: the Ca2+ binding subunit, troponin C (TnC),1 the inhibitory subunit, troponin I (TnI), and troponin T (TnT) which anchors the troponin complex to the thin filament. The binding of Ca2+ to TnC results in conformational changes and altered interactions within the thin filament which ultimately lead to muscle contraction (1). Central to the transmission of the Ca2+ signal are altered interactions between TnC and TnI.

Skeletal and cardiac TnC share ~70% sequence identity and consist of two globular domains (N- and C-terminal) connected by a central helix (2). Both proteins have four EF hand divalent cation binding sites, sites I and II in the N-terminal domain and sites III and IV in the C-terminal domain. All four sites bind Ca2+ in skeletal TnC (skTnC), but in cardiac TnC (cTnC) site I is unable to bind divalent cations (3).

Sites I and II of skTnC and site II of cTnC are low affinity Ca2+-specific binding sites (Ka(Ca) = 5 × 106 M-1 and 2 × 106 M-1 for skTnC and cTnC, respectively) (4, 5). It is Ca2+ binding to these sites which is proposed to act as the trigger for the initiation of muscle contraction. In skTnC this involves an "opening" of the structure with increased exposure of an extensive hydrophobic patch to which skeletal troponin I (skTnI) binds, ultimately relieving inhibition on actin (6). There is, however, evidence that the details of interaction between TnC and TnI may differ in cardiac and skeletal muscle as the Ca2+-saturated N-terminal domain of cTnC exists in a closed conformation (7), and a recent report suggests that the binding of cTnI147-163 is required for the "opening" of this domain (8).

Sites III and IV in cTnC are high affinity Ca2+ binding sites that can also bind Mg2+ with a lower affinity (Ka(Ca) = 3 × 108 M-1 and Ka(Mg) = 3 × 103 M-1) (5). Under physiological conditions these sites are always occupied by Mg2+ or Ca2+. The C-terminal domain of TnC has been proposed as a Ca2+-independent structural binding site for TnI and TnT, helping to anchor the troponin complex to the thin filament (9).

Although the crystal and solution structures of skTnC and cTnC are well characterized (2, 7, 10, 11) only low resolution data are available for the structure of TnI (12-14). Several lines of evidence indicate that TnI lies antiparallel to TnC and that the two proteins interact at several sites along their length (1). The structures of skTnC bound to skTnI1-47 and cTnC C-domain bound to the equivalent region of cTnI (residues 33-80) show this region of TnI to be alpha -helical and to bind to the hydrophobic pocket of the C-terminal domain of TnC by both polar and Van der Waals interactions (15, 16). Both of these studies were carried out with Ca2+-saturated TnC, although it has not been determined if the C-terminal sites are bound with Mg2+ at all times, or if the increase in [Ca2+] on activation is of sufficient duration to displace Mg2+ in the contractile state. In relaxed muscle, at low [Ca2+], interactions of the C-terminal domain of TnC with the N-terminal region of TnI will still persist, but the inhibitory region of TnI (residues 104-115 in skTnI, residues 136-147 in cTnI) and a region C-terminal to this (residues 140-148 in skTnI, residues 152-199 in cTnI) are thought to bind to actin, inhibiting the actomyosin ATPase. On activation, when the regulatory site(s) of TnC are occupied by Ca2+, these sites on TnI bind to TnC, relieving inhibition (for review, see Ref. 17). Although much is known about the interaction of TnI with TnC, further information is required for us to understand fully their role in muscle regulation.

In this study isothermal titration microcalorimetry (ITC) has been used to investigate the interaction of cTnI with cTnC and its isolated domains. We have for the first time investigated the effect of ionic strength and Ca2+ on the free energy, enthalpy, and entropy changes associated with the binding of cTnC and its isolated domains to cTnI. Our results suggest that the C-terminal domain of cTnC may play a more important role in cardiac muscle regulation than previously thought.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Restriction endonucleases, DNA-modifying enzymes, and deoxynucleotides were purchased from New England Biolabs, Taq polymerase was purchased from Roche Diagnostics Ltd., and oligonucleotide primers were produced by Alta Bioscience, University of Birmingham. pET11c(cTnC) and pET11c(cTnI) DNA constructs were kindly provided by Dr. E. Al-Hillawi. Inorganic chemicals were of Analar quality from BDH Laboratory Supplies. DEAE-Sepharose Fast Flow, CM-Sepharose Fast Flow, and Superdex 75 were obtained from Amersham Pharmacia Biotech. BCA protein assay reagent (bicinchoninic acid) was obtained from Pierce Chemical Company and used as per the manufacturer's instructions.

Expression and Purification of cTnC, cTnC N-domain, and cTnC C-domain-- Polymerase chain reaction was used to generate DNA fragments encoding the isolated N-terminal domain of cTnC (cTnC N-domain, residues 1-91 inclusive of N-terminal Met), and cTnC C-domain (residues 91-161). The 5'-polymerase chain reaction primer (5'-GGGAATTCATATGGATGACATCTACAAGGCTGC-3') for the cTnC N-domain was designed to amplify pET11c(cTnC) DNA from the first amino acid and also encoded an NdeI restriction site. The 3'-primer (5'-AAGGATCCCTACCCTTTGCTGTCGTCCTT-3') corresponded to amino acids 86-91 and also encoded a stop codon upstream of a BamHI site. To generate the cTnC C-domain a 5'-amplification primer (5'-GGGAATTCATATGGGGAAATCTGAGGAGGAG-3') was designed to amplify the pET11c(cTnC) DNA sequence from Gly-91 to the 3'-end of the coding sequence. This 5'-primer also encoded an NdeI restriction site. The 3'-primer (5'-GGGGATCCCTACTCCACACCCTTCATGAAC-3') was complementary to pET11c(cTnC) DNA encoding the C terminus of cTnC; this primer also encoded a stop codon and BamHI site.

The resulting polymerase chain reaction products were purified to a single band by gel electrophoresis on a 7.5% polyacrylamide gel and electroeluted. The clean products were digested with NdeI and BamHI, ligated into NdeI/BamHI-digested pET11c vector, and used to transform competent Escherichia coli JM101 cells. Successful clones were screened for by restriction analysis and verified by DNA sequencing and by amino acid sequencing of the first 10 residues of the purified protein.

The cTnC, cTnC N-domain, and cTnC C-domain pET11c constructs were transformed into and expressed in E. coli BL21(DE3) cells. The cells were grown at 37 °C in NZCYM medium with 0.3 mM ampicillin until they reached an A600 of 0.8-1. They were then induced with 0.5 mM isopropyl beta -D-thiogalactopyranoside and incubated for a further 4-5 h. The cells were harvested by centrifugation at 5,000 × g for 10 min. Harvested cells were homogenized into 25 mM triethanolamine hydrochloride, pH 7.5, 8 M urea, 2 mM EDTA, 1 mM dithiothreitol. The homogenate was then sonicated for 9 × 20 s at power level 6 using a Heatsystems Inc. sonicator. Insoluble cell debris was pelleted by centrifugation at 75,000 × g for 40 min at 4 °C. The cell extract was loaded onto a DEAE-Sepharose Fast Flow column (2.5 × 20 cm), equilibrated with 25 mM triethanolamine hydrochloride, pH 7.5, 8 M urea, 2 mM EDTA, 1 mM dithiothreitol buffer, and eluted with a linear 0-0.5 M NaCl gradient. The fractions containing cTnC or its domains were identified by absorption at 280 nm and SDS-polyacrylamide gel electrophoresis. These fractions were dialyzed against 1 mM ammonium bicarbonate and freeze dried. The lyophilized protein was dissolved in 25 mM triethanolamine hydrochloride, pH 7.5, 150 mM NaCl, 1 mM dithiothreitol, loaded on a Superdex-75 column (2.5 × 50 cm), and eluted in the same buffer. The fractions containing cTnC or its domains were pooled and dialyzed against 1 mM ammonium bicarbonate, freeze dried and stored at -20 °C. The isolated proteins were judged to be ~95% pure by SDS-polyacrylamide gel electrophoresis analysis.

Expression and Purification of cTnI-- The expression of cTnI was as described by Al-Hillawi et al. (18). Ammonium sulfate (30% w/v) was added to cTnI cell extract in 25 mM triethanolamine hydrochloride, pH 7.5, 8 M urea, 2 mM EDTA, 1 mM dithiothreitol buffer, and the solution was centrifuged at 15,000 × g for 10 min. The cTnI remained in the supernatant and was dialyzed against 25 mM triethanolamine hydrochloride, pH 7.5, 8 M urea, 2 mM EDTA, 1 mM dithiothreitol. The cTnI was then loaded onto a CM-Sepharose Fast Flow column (2.5 × 20 cm) equilibrated with the same buffer and eluted with a linear 0-0.5 M NaCl gradient. The fractions containing cTnI were identified by absorption at 280 nm and SDS-polyacrylamide gel electrophoresis, pooled, dialyzed against 1 mM HCl, freeze dried, and stored at -20 °C.

Analytical Methods-- 12% SDS-polyacrylamide gel electrophoresis gels were run at 35 mA and stained with Coomassie Blue (19). DNA and N-terminal protein sequencing were carried out on Applied Biosystems 373A and 437A automated sequencers respectively by Alta Bioscience, School of Biosciences, University of Birmingham. Protein concentrations were determined by the bicinchoninic acid method calibrated with bovine serum albumin (Pierce Chemical Company).

Isothermal Titration Microcalorimetry-- Experiments were carried out using a Microcal Inc. isothermal titration microcalorimeter. Proteins were dialyzed extensively against 20 mM MOPS, pH 7.0, 3 mM MgCl2, 0.5 mM EGTA, ± 1 mM CaCl2, with 0-0.3 M KCl and experiments performed at 30 °C. Protein samples were clarified by centrifugation at 86,000 × g for 20 min with a TL-100 ultracentrifuge (Beckman Instruments Co.) prior to protein concentration determination. The sample cell was filled with 1.4 ml of cTnI solution and titrated with cTnC, cTnC N-domain, or cTnC C-domain. Protein concentrations were 3 µM (+Ca2+) or 6 µM (-Ca2+) cTnI solution in the cell titrated with 60 µM (+Ca2+) or 160 µM (-Ca2+) cTnC or cTnC C-domain. When cTnI was titrated with cTnC N-domain in the presence of Ca2+ concentrations were 6 and 160 µM, respectively. The injection size was 5 µl, with duration of 10 s, at 210-s intervals with stirring at 350 rpm. Control titrations of buffer with cTnC or its isolated domains and titrations of cTnI with buffer indicated that heats of dilution were small and constant. In each experiment the heat of dilution was obtained from additional injections following complete saturation and was subtracted from the binding isotherm. OriginTM ITC data analysis software (Microcal Inc.) was used in the "one set of sites" mode to analyze all binding isotherms.

Sedimentation Equilibrium-- These studies were performed with a model E analytical ultracentrifuge (Beckman Instruments Co.) equipped with Raleigh interference optics. The method used was the long column meniscus depletion technique as described by Chervenka (20). An AN-D rotor was used together with a 12-mm double-sector synthetic boundary cell fitted with sapphire windows. All of the samples were dialyzed overnight against a buffer containing 20 mM MOPS, pH 7.0, 3 mM MgCl2, 0.5 mM EGTA ± 1 mM CaCl2 and either 0, 0.05, 0.1, or 0.3 M KCl. Protein samples were centrifuged at 86,000 × g for 20 min with a TL-100 ultracentrifuge prior to analytical ultracentrifugation. Ultracentrifugation data were obtained with a rotor speed of 35,000 rpm at 30 °C over a range of cTnI concentrations from 10 to 30 µM. The interference patterns were photographed on Kodak TSK 400 film. The developed film was then read on a Nikon two-dimensional microcomparator. The fringe displacement as a function of radial distance was then measured for two fringes and the average obtained. Equilibrium was established when no further fringe displacement occurred with time and was attained after a 6-h ultracentrifugation. The average molecular mass for the whole solution was calculated from the slope of the plot of the natural logarithm of the fringe displacement (lnf) against the distance from the center of rotation squared (r2). All fringe displacements greater than 100 µm were included in the least squares analysis. The relationship between the Mr and slope of the lnf versus r2 plot is given by Equation 1,


m<SUB>r</SUB>=2RT/&ohgr;<SUP>2</SUP>(1−&ngr;&rgr;) · <UP>dlnf/d</UP>r<SUP>2</SUP> (Eq. 1)
where R is the gas constant expressed as 8.313 J K-1 mol-1, omega  is the angular velocity (2pi /60 * rpm (rad. s-1)), rho  is the solvent density, and nu  the partial specific volume of the protein (0.72 g ml-1). The nu  was calculated from the known amino acid composition of cTnI (21). The density rho  was estimated using standard tables (22).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The Effect of Temperature on the Delta H of cTnC·cTnI Binding-- To determine the optimum temperature at which to monitor cTnC·cTnI binding, the effect of temperature on the binding enthalpy was studied between 16 and 37 °C (Fig. 1). In the absence of Ca2+ (but in the presence of Mg2+) the Delta H was +4 kJ mol-1 at 16 °C. As the temperature was increased, Delta H decreased linearly to -46 kJ mol-1 indicating exothermic binding at physiological temperatures. The slope of this plot yields Delta Cp, the heat capacity of the binding process. Delta Cp was -2.4 ± 0.1 kJ mol-1 K-1 in the absence of Ca2+. These results also indicate that the minimum temperature at which Delta H was large enough to obtain good data in the absence of Ca2+ was 30 °C. This temperature was therefore used for all further experiments. In the presence of Ca2+ the binding process was considerably more exothermic across the entire temperature range, although Delta Cp was similar (-2.2 ± 0.1 kJ mol-1 K-1). The large negative value of Delta Cp upon cTnC·cTnI binding is probably accounted for by a decrease in the solvent-exposed nonpolar surface area (23). This could be the result of movement of apolar residues within cTnC and/or cTnI on interaction or, more probably, the burial of hydrophobic residues at the binding interface. The fact that Delta Cp is very similar in the presence and absence of Ca2+ is consistent with the binding of the cTnC N-domain binding to cTnI being thermally neutral under these conditions (see Fig. 5a). This suggests that the area of nonpolar residues buried at the cTnC C-terminal domain/cTnI interface is similar in the presence of Mg2+ or Ca2+.


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 1.   The temperature dependence of Delta H associated with cTnC binding to cTnI. The Delta H for cTnC binding to cTnI was measured at eight temperatures. Assay conditions were 20 mM MOPS, pH 7.0, 0.3 M KCl, 3 mM MgCl2, 0.5 mM EGTA, in the absence or presence of 1 mM CaCl2. Protein concentrations were: 6 µM cTnI and 160 µM cTnC (-Ca2+) () or 3 µM cTnI and 60 µM cTnC (+Ca2+) (open circle ).

Proton Release during cTnC·cTnI Binding-- If the cTnC·cTnI binding process results in a net release or absorption of protons then an equivalent number of protons must be absorbed or released by the buffer. This process will contribute to the observed Delta H for cTnC·cTnI binding and therefore has to be accounted for. To assess whether there is a significant absorption or release of protons upon cTnC·cTnI complex formation Delta H was measured in experiments using buffers with enthalpies of ionization ranging from -2.35 to +36.51 kJ mol-1 (cacodylate, Pipes, MOPS, and imidazole) (24). The results in Fig. 2 show that the observed Delta H changed very little, either in the presence or absence of Ca2+, and was not dependent on the buffer, demonstrating that there was little or no net release or absorption of protons during binary complex formation.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of protonation/deprotonation on cTnI·cTnC binding energetics. The Delta H of cTnC binding to cTnI was measured in buffers with different ionization enthalpies. Assay conditions were: 20 mM buffer (cacodylate, MOPS, imidazole, or Tris), pH 7.0, 0.3 M KCl, 3 mM MgCl2, 0.5 mM EGTA, in the absence or presence of 1 mM CaCl2. Protein concentrations were 6 µM cTnI and 160 µM cTnC (-Ca2+) () or 3 µM cTnI and 60 µM cTnC (+Ca2+) (open circle ). Each data point represents the mean Delta H of cTnC·cTnI binding from four independent determinations ±S.E.

Binding of cTnC to cTnI-- Initially the experiments were performed in the presence of 0.3 M KCl to allow comparison with previous work (25, 26). The result of a typical ITC experiment is illustrated in Fig. 3. A trace of the calorimetric titration of cTnI with cTnC in the absence of Ca2+ is shown (Fig. 3a). The negative peaks show that the interaction is exothermic. Each deflection represents the heat released by cTnC binding to cTnI with each injection. The binding isotherm derived from these data is plotted in Fig. 3b. This graph shows the integrated heats for each cTnC injection versus the molar ratio of cTnC to cTnI. From these data the stoichiometry (n), binding constant (Ka) and enthalpy (Delta H) of binding were obtained directly, and the changes in Gibbs free energy (Delta G) and entropy (TDelta S) of binding were calculated using Equation 2.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Microcalorimetric titration of cTnI with cTnC. Panel a, trace of the calorimetric titration of 6 µM cTnI with 160 µM cTnC at 30 °C, 20 mM MOPS, pH 7.0, 0.3 M KCl, 3 mM MgCl2, 0.5 mM EGTA. Panel b, binding isotherm obtained from the experiment shown in panel a.


&Dgr;G=<UP>−</UP>RT <UP>ln</UP> K<SUB>a</SUB>=&Dgr;H−T&Dgr;S (Eq. 2)
The average Ka, Delta H, Delta G, and TDelta S values from a minimum of five independent ITC binding experiments are given in Table I. As expected, the Ka was ~ 6-fold higher (17.4 × 107 M-1) in the presence of Ca2+ than in the absence of Ca2+ (2.7 × 107 M-1). The binding stoichiometry was essentially 1:1 under both sets of conditions.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Binding parameters for complexation between cTnI and cTnC or cTnC C-domain
The binding parameters were obtained from data similar to those shown in Fig. 3. The parameters are given as the mean ± S.E. obtained from a minimum of five independent determinations. Assay conditions were: 20 mM MOPS, pH 7.0, 0.3 M KCl, 3 mM MgCl2, 0.5 mM EGTA (-Ca2+), with or without 1 mM CaCl2 (+Ca2+). 6 µM (-Ca2+) or 3 µM (+Ca2+) cTnI was titrated with 5 µl of 160 µM (-Ca2+) or 60 µM (+Ca2+) cTnC or cTnC C-domain.

Binding of cTnI to the cTnC N- and C-domains-- Initial studies of the binding of the cTnC N- and C-domains were carried out under conditions identical to those employed for intact cTnC. The results summarized in Table I show striking similarities for the thermodynamic properties of whole cTnC and cTnC C-domain binding to cTnI. The large negative enthalpy change drives complex formation in both cases although there is a small entropic contribution in the absence of Ca2+. The affinities of cTnC and cTnC C-domain for cTnI were very similar in the presence of Ca2+ but higher than those in the absence of Ca2+. This indicates that the C-terminal domain of cTnC is the major contributor to the overall binding affinity of cTnC to cTnI. We find that Ca2+-saturated cTnC C-domain binds to cTnI with an 8 fold higher affinity than the Mg2+-saturated cTnC C-domain. Control binding assays with increased concentrations of Mg2+ (up to 10 mM) gave binding parameters identical to assays performed under standard conditions, indicating that the cTnC C-domain was fully saturated with Mg2+ in the presence of 3 mM Mg2+.

Attempts to monitor the binding of the isolated cTnC N-domain to cTnI in the presence of Ca2+ proved unsuccessful in the presence of 0.3 M KCl, even at different temperatures (data not shown). Consequently studies were undertaken to investigate the effect of ionic strength on the binding of whole cTnC, cTnC N- and C-domains to cTnI.

Effect of Ionic Strength on cTnC and Its Isolated Domains Binding to cTnI-- The effect of increasing ionic strength on the binding of cTnC to cTnI is shown in Fig. 4a. In the absence of Ca2+ (Mg2+ only) the affinity of cTnC for cTnI decreased as the ionic strength was increased, whereas in the presence of Ca2+ the affinity increased as ionic strength was increased. Similar trends were observed when cTnI was titrated with cTnC C-domain (Fig. 4b). In the absence of Ca2+ the affinity of the cTnC C-domain for cTnI decreased dramatically as the ionic strength was increased, and in the presence of Ca2+ the affinity of cTnC C-domain for cTnI increased slightly as ionic strength was increased.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of ionic strength on the binding of cTnC and its isolated domains to cTnI. Assay conditions were: 20 mM MOPS, pH 7.0, 3 mM MgCl2, 0.5 mM EGTA, 30 °C, with increasing KCl concentrations, in the absence or presence of 1 mM CaCl2. Panel a, effect of increasing ionic strength on the binding of cTnC to cTnI. Protein concentrations were 6 µM cTnI and 160 µM cTnC (-Ca2+) () or 3 µM cTnI and 60 µM cTnC (+Ca2+) (open circle ). Panel b, effect of increasing ionic strength on the binding of cTnC C-domain and cTnC N-domain to cTnI. Protein concentrations were: 6 µM cTnI and 160 µM cTnC C-domain (-Ca2+) (black-diamond ), 3 µM cTnI and 60 µM cTnC C-domain (+Ca2+) (×) or 6 µM cTnI and 160 µM cTnC N-domain (+Ca2+) (Delta ). Each data point shown is the mean of at least three independent determinations ± S.E.

cTnC N-domain bound to cTnI in both the presence and absence of Ca2+ in the 0-0.1 M KCl range. In the presence of Ca2+, binding of the cTnC N-domain to cTnI was exothermic, equimolar, decreased slightly as ionic strength was increased, and was ~8-fold weaker than that of the cTnC C-domain under similar conditions (Fig. 4b). In the absence of Ca2+, binding was endothermic and therefore must be entropically driven. However, conditions could not be found to increase the cTnC N-domain/cTnI stoichiometry much beyond ~0.5, making the data difficult to interpret. The endothermic binding of cTnC N-domain to cTnI in the absence of Ca2+ also appeared to contribute to the binding of whole cTnC to cTnI, at concentrations of KCl less than 0.1 M, giving rise to a two-site binding curve that was difficult to interpret, hence these data are not shown.

Effect of Ionic Strength on Enthalpy and Entropy of Binding-- The effect of varying the ionic strength on Delta H and TDelta S of cTnC and its isolated domains binding to cTnI resulted in the linear plots shown in Fig. 5, a and b, respectively. The thermodynamic parameters of cTnC C-domain binding to cTnI closely paralleled those obtained with whole cTnC both in the presence and absence of Ca2+ and were quite dissimilar to those observed for the cTnC N-domain. The Delta H observed for cTnC N-domain binding to cTnI approached zero as the ionic strength was increased. Because ITC monitors the heat change as a result of complex formation a very small Delta H made it difficult to measure cTnC N-domain/cTnI binding affinities at ionic strengths greater than 0.1 M. The Delta H and TDelta S results show that changes in enthalpy were the driving force for the interaction between cTnC and cTnC C-domain with cTnI both in the presence and absence of Ca2+, as both Delta H and TDelta S values were negative over most of the range of salt concentrations studied. The interaction between cTnC N-domain and cTnI is entropically favorable at low salt concentrations and entropy would be the only driving force at physiological ionic strength (as determined from extrapolation of Fig. 5, a and b).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of increasing ionic strength on the enthalpy and entropy associated with the binding of cTnC and its isolated domains to cTnI. Panel a, Delta H, and panel b, TDelta S. Data were obtained from the binding of cTnI to cTnC in the presence (open circle ) and absence () of Ca2+, cTnC C-domain in the presence (×) and absence (black-diamond ) of Ca2+, and cTnC N-domain the presence of Ca2+ (triangle . Each data point shown is the mean of at least three independent determinations (± S.E. shown for Delta H). For conditions, see the legend to Fig. 4.

Sedimentation Equilibrium Studies on cTnI-- Because of the potential of cTnI to aggregate it was important to show that aggregation was not the cause of differences in cTnC·cTnI binding observed at different ionic strengths. Sedimentation equilibrium experiments were therefore performed on cTnI under the conditions used for ITC. A typical plot illustrating the relationship between the lnf and the square of the distance from the axis of rotation (r2) is shown in Fig. 6. The linear relationship of this analysis over the entire length of the solution column demonstrates that the cTnI is monodisperse in solution. Furthermore, this linearity was observed over all of the KCl and protein concentrations used and in the presence and absence of Ca2+. The estimated molecular mass obtained for cTnI by sedimentation equilibrium, by averaging the molecular mass at all KCl conditions, was 22.6 ± 1.1 kDa (S.E.). This agrees with the known molecular mass of cTnI (23,906 Da) calculated from the amino acid composition and observed in this laboratory by mass spectrometry.2


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 6.   Sedimentation equilibrium of cTnI. Analytical ultracentrifugation conditions were: 20 mM MOPS, pH 7.0, 0.1 M KCl, 3 mM MgCl2, 1 mM CaCl2, 0.5 mM EGTA, 30 °C. An AN-D rotor was used to centrifuge cTnI (20 µM) at 35,000 rpm for 7 h. The plot shows the radial distance squared (r2) versus the lnf. The molecular mass calculated from the linear regression of r2 versus lnf was 23,670 Da. The bottom of the cell is indicated by a black arrow.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Fluorescence and surface plasmon resonance studies have been used previously to establish the affinity of cTnC for cTnI, e.g. (25-28). Although these methods have provided much valuable information, fluorescence techniques require modification of the proteins with reporter groups, and surface plasmon resonance produces orientation constraints because of protein immobilization. We have used ITC, a technique for directly measuring Ka and Delta H values in biological systems, to examine the binding of cTnC to cTnI under a variety of ionic conditions. No protein modification was required, and the experiments were performed with the proteins free in solution. Furthermore, we have studied the binding of the recombinant N- and C-terminal domains of cTnC to cTnI. Previous studies, using a variety of techniques, have shown that the isolated domains of both skeletal and cardiac TnC have structures and properties very similar to those in the intact proteins (16, 29, 30).

Because it is known that TnI has a tendency toward self-association, it was important to ascertain whether it was monomeric or forming aggregates in solution, under the conditions used in the ITC experiments. From the sedimentation equilibrium studies the linearity of the graphic analysis was consistent with sample homogeneity. No indication of dimerization or higher order aggregation was ever observed, even in the absence of KCl, in the presence or absence of Ca2+, with protein concentrations higher than those used for ITC. Furthermore, previous studies from our laboratory (31) have demonstrated that both cTnC and the cTnC·cTnI complex show no tendency toward aggregation at and above the protein concentrations used in these ITC experiments. These data indicate that the protein solutions used for the ITC experiments were all monodisperse and that effects of ionic strength on binding were not caused by protein aggregation. The fact that all observed binding ratios of cTnC (or its isolated domains) with cTnI were essentially 1:1 under all conditions studied is consistent with this finding.

The results show that the affinity of cTnC for cTnI is strongly dependent on ionic strength. All previously reported measurements of the affinity of cTnC for cTnI were obtained at concentrations of 0.3 M KCl or greater (25-28). At these high ionic strengths the affinity of cTnC for cTnI was significantly higher in the presence of Ca2+ than in the presence of Mg2+, as we have found here. At physiological ionic strength, however, we found no increase in the affinity of cTnC for cTnI upon addition of Ca2+. These data suggest that around physiological ionic strength the cTnC/cTnI interaction in the presence and absence of Ca2+ is finely balanced, although Ca2+ clearly changes the mode of interaction as demonstrated by changes in Delta H and TDelta S. It should be noted, however, that we have of necessity investigated only the isolated binary interaction between cTnC and cTnI in these studies. It is possible that the other thin filament protein components could influence the effect of ionic strength on the Ca2+ sensitivity of the cTnC/cTnI interaction.

We find that the effect of Ca2+ and ionic strength on the affinity and thermodynamic parameters of the cTnC C-domain binding to cTnI closely parallel those found with whole cTnC. These data suggest that the C-terminal domain of cTnC dominates the steady-state interaction with cTnI in both the presence and absence of Ca2+. These results contrast sharply with the binding of cTnC N-domain to cTnI over the limited ionic strength range where we were able to obtain data. Even in the presence of Ca2+ the affinity of cTnI for the cTnC N-domain was significantly lower than that measured for the cTnC C-domain. It is interesting to note that where data for the binding of cTnI to the isolated domains of cTnC can be compared with whole cTnC, considerable constraints occur in the latter interaction. For example, at 0.1 M KCl in the presence of Ca2+, if we consider that cTnI binds simultaneously to both domains of TnC and that the overall affinity is the product of the individual Ka values for both domains, then one would expect to find a Ka for cTnC·cTnI in the 1014 M-1 range (Fig. 5b). Clearly the interactions of the two domains of whole cTnC with cTnI are not independent and influence one another.

We observed that the binding of cTnC and cTnC C-domain to cTnI were dramatically affected by the addition of Ca2+ over a range of ionic strengths. In the absence of Ca2+, the reduction in Ka as the ionic strength was increased, both for the C-terminal domain of cTnC and whole cTnC, may suggest that electrostatic interactions dominate the binding when Mg2+ occupies sites III and IV. On the other hand, when Ca2+ is bound to these sites, increasing the ionic strength increased the affinity, especially between the intact proteins, a characteristic of interactions in which hydrophobic forces dominate. This agrees with NMR (16) and crystallographic data (15) that show extensive Van der Waals interactions between TnC and TnI in the presence of Ca2+. It also suggests a difference in the structure of the C-terminal domain of cTnC when it is occupied by Mg2+ or Ca2+. It may be that Ca2+ occupancy of sites III and IV "opens" up the paired EF hands exposing hydrophobic sites as seen in the crystal structures of skTnC (2) and skTnC bound to the N-terminal region of skTnI (15), whereas Mg2+ is not able to do this fully. There is presently no high resolution structure for TnC with Mg2+ bound in sites III and IV, which would be particularly valuable to compare with the Ca2+-bound state. Several previous studies are consistent with our findings. Different fluorescence changes were found within the C-terminal domain of skTnC depending upon whether Mg2+ or Ca2+ were bound (32, 33). Analysis of the binding of Mg2+ and Ca2+ to cTnC by microcalorimetry suggests that Mg2+ and Ca2+ induce different conformations of the C-terminal domain of cTnC (34).3 Microcalorimetry has also been used to show that conformational changes occur in the C-terminal domain of skTnC when Ca2+ replaces Mg2+ in sites III and IV, although these differ somewhat from those observed in the cardiac isoform (35).

Our data demonstrate, for the first time, that there are structural differences within the C-terminal domain of cardiac TnC, depending on whether Ca2+ or Mg2+ is bound, which affect the characteristics of the cTnI/cTnC interaction. Experiments with skeletal isoforms also suggest Ca2+ sensitivity in the binding of skTnC C-terminal domain to skTnI. An increase in the affinity of a skTnC tryptic fragment, corresponding to the C-terminal domain of skTnC, for skTnI in the presence of Ca2+ has been noted previously (36). Additionally, Pearlstone and Smillie (37) found that a higher ionic strength was required to elute the C-terminal domain of skTnC from a skTnI peptide affinity column in buffer containing Ca2+ rather than Mg2+. The difference in cTnC·cTnI affinity would be important if Ca2+ can exchange for Mg2+ at sites III and IV in working cardiac muscle. It has not been determined if the C-terminal sites of TnC are bound with Mg2+ at all times or if the Ca2+ signal is of sufficient duration to displace Mg2+ in the contractile state. Although modeling studies (38) suggest that Mg2+ dissociation from sites III and IV is likely to be too slow to be completed in a single contraction-relaxation cycle, they also predict that Ca2+ occupancy of the C-terminal domain of cTnC is a measure of the intensity and frequency of muscle contraction and could therefore increase with increased heart rate. This would lead to a change in the structure of cTnC and enhanced affinity for cTnI, allowing the C-terminal domain of cTnC to play a modulatory role in the regulation of the contractile cycle. Our results give no indication as to whether the change in affinity of cTnC C-domain for cTnI, in the presence and absence of Ca2+, reflects a different mode of binding to residues 33-80 of cTnI or whether a different region of cTnI displaces the cTnI helix at positions 33-80 in response to Ca2+ as in the model proposed by Tripet (39).

The thermodynamic results obtained by ITC give some interesting insights into the cTnC/cTnI interaction. Previously the Delta G difference between Ca2+- and Mg2+-bound states of cTnC binding to cTnI, at 0.4 M KCl, was attributed solely to Ca2+ binding to "regulatory" site II in the N-terminal domain of cTnC (40). This change in Delta G was thought to be responsible for Ca2+ activation in cardiac muscle. Our data suggest that at high ionic strengths most of the Ca2+-dependent increase in Delta G of cTnC binding to cTnI arises from Ca2+ binding to sites III and IV. Our results demonstrate that any differences between the steady-state binding of the Mg2+ and Ca2+ forms of cTnC to cTnI cannot solely be attributed to Ca2+ binding to the N-terminal domain of cTnC.

Parallels can be drawn between our cTnC·cTnI work and published ITC data on calmodulin-target peptide recognition (41, 42). Quantitatively similar Delta H, TDelta S, and Delta Cp values and negligible proton release are seen in both cases. The negative Delta Cp values indicate internalization of hydrophobic surfaces upon complex formation, a process that is entropically favorable. Wintrode and Privalov (41) considered that burial of hydrophobic surfaces could not be the major driving force in the enthalpically driven binding of calmodulin to target peptide. However, it cannot be excluded that the entropy associated with the burial of hydrophobic surfaces is important in offsetting unfavorable entropy changes arising from noncovalent bond formation and increased order in the cTnC·cTnI complex. Both domains of calmodulin appear to contribute similarly to the overall Delta H of target peptide binding (41), whereas tissue-specific adaptations of the cardiac homolog, cTnC, to muscle regulation result in very different contributions of the cTnC N-terminal and C-terminal domains to the overall Delta H.

This study has revealed the importance of ionic strength on the cTnC/cTnI interaction, which must be considered when interpreting data. Large changes in the Delta H of cTnC·cTnI binding, but little change in affinity at physiological ionic strength, could imply that the mode but not the strength of the cTnC/cTnI interaction changes in response to Ca2+. We have also demonstrated that the interaction between cTnC C-domain and cTnI is Ca2+-sensitive and that cTnC C-domain is responsible for most of the energy difference observed between cTnC·cTnI binding in the presence and absence of Ca2+. Further studies are required to clarify the importance of the cTnC C-domain in regulation. It will be interesting to compare the results obtained for cTnC and its isolated domains binding to cTnI with data obtained using the skeletal isoforms, where significant differences in sequence and binding occur.

    ACKNOWLEDGEMENTS

We thank Sue Brewer and Giles Fairhead for the production of the cTnC C-domain and cTnC N-domain clones, respectively. We thank Nina Sewell and Sue Brewer for technical assistance and Dr. Rudolf Allemann and Richard Swanwick for helpful discussions.

    FOOTNOTES

* This work was supported in part by the Wellcome Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of Wellcome Prize Studentship Grant 050031/Z/97/Z.

§ To whom correspondence should be addressed: School of Biosciences, the University of Birmingham, P.O. Box 363, Edgbaston, Birmingham B15 2TT, UK. Tel.: 44-121-414-5401; Fax: 44-121-414-2597; E-mail: i.p.trayer@bham.ac.uk.

Published, JBC Papers in Press, July 31, 2000, DOI 10.1074/jbc.M005764200

2 M. J. Calvert, D. G. Ward, P. Ashton, and I. P. Trayer., unpublished results.

3 D. G. Ward and M. J. Calvert, unpublished data.

    ABBREVIATIONS

The abbreviations used are: TnC, troponin C; TnI, troponin I; TnT, troponin T; cTnI, human cardiac troponin I; cTnC, human cardiac troponin C; cTnC N-domain, recombinant human cardiac troponin C N-terminal domain (residues 1-91); cTnC C-domain, recombinant human cardiac troponin C C-terminal domain (residues 91-161); skTnI, troponin I from skeletal muscle; skTnC, troponin C from skeletal muscle; ITC, isothermal titration microcalorimetry; MOPS, 3-(N-morpholino)propanesulfonic acid; lnf, logarithm of fringe displacement; Pipes, 1,4-piperazinediethanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Farah, C. S., and Reinach, F. C. (1995) FASEB J. 9, 755-767
2. Herzberg, O., and James, M. N. G. (1985) Nature 313, 653-659
3. Van Eerd, J.-P., and Takahashi, K. (1976) Biochemistry 15, 1171-1180
4. Potter, J. D., and Gergely, J. (1975) J. Biol. Chem. 250, 4628-4635
5. Holroyde, M. J., Robertson, S. P., Johnson, D. J., Solaro, J. R., and Potter, J. D. (1980) J. Biol. Chem. 255, 11688-11693
6. Gagne, S. M., Tsuda, S., Li, M. X., Smillie, L. B., and Sykes, B. D. (1995) Nature Struct. Biology 2, 784-789
7. Sia, S. K., Li, M. X., Spyracopoulos, L., Gagne, S. M., Liu, W., Putkey, J. A., and Sykes, B. D. (1997) J. Biol. Chem. 272, 18216-18221
8. Li, M. X., Spyracopoulos, L., and Sykes, B. D. (1999) Biochemistry 38, 8289-8298
9. Malnic, B., Farah, C. S., and Reinach, F. C. (1998) J. Biol. Chem. 273, 10594-10601
10. Houdusse, A., Love, M. L., Dominguez, R., Grabarek, Z., and Cohen, C. (1997) Structure 5, 1695-1711
11. Slupsky, C. M., and Sykes, B. D. (1995) Biochemistry 34, 15953-15964
12. Olah, G. A., Rokop, S. E., Wang, C. L. A., Blechner, S. L., and Trewhella, J. (1994) Biochemistry 33, 8233-8239
13. Olah, G. A., and Trewhella, J. (1994) Biochemistry 33, 12800-12806
14. Stone, D. B., Timmins, P. A., Schneider, D. K., Krylova, I., Ramos, C. H. I., Reinach, F. C., and Mendelson, R. A. (1998) J. Mol. Biol. 281, 689-704
15. Vassylyev, D. G., Takeda, S., Wakatsuki, S., Maeda, K., and Maeda, Y. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 4847-4852
16. Gasmi-Seabrook, G., Howarth, J. W., Finley, N., Abusamhadneh, E., Gaponenko, V., Brito, R. M. M., Solaro, J. R., and Rosevar, P. R. (1999) Biochemistry 38, 8313-8322
17. Perry, S. V. (1999) Mol. Cell. Biochem. 190, 9-32
18. Al-Hillawi, E., Minchin, S. D., and Trayer, I. P. (1994) Eur. J. Biochem. 225, 1195-1201
19. Weeds, A. G., Hall, R., and Spurway, N. C. (1975) FEBS Lett. 49, 320-324
20. Chervenka, C. H. (1970) Anal. Biochem. 34, 24-49
21. Cohn, E. J., and Edsall, J. T. (1943) Proteins, Amino Acids and Peptides , pp. 370-381, Reinhold Publishing Corporation, New York
22. Handbook of Chemistry and Physics, pp. 79
23. Spolar, R. S., and Recordm, M. T., Jr (1994) Science 263, 777-784
24. Christensen, J. J., and Hansen, L. D. (1976) Handbook of Proton Ionization Heats , Wiley, New York
25. Al-Hillawi, E., Bhandari, D., Trayer, H. R., and Trayer, I. P. (1995) Eur. J. Biochem. 228, 962-970
26. Dong, W. J., Chandra, M., Xing, J., She, M. D., Solaro, R. J., and Cheung, H. C. (1997) Biochemistry 36, 6754-6761
27. Liao, R., Wang, C.-K., and Cheung, H. C. (1994) Biochemistry 33, 12729-12734
28. Reiffert, S., Jaquet, K., Heilmeyer, L. M. G., and Herberg, F. W. (1998) Biochemistry 37, 13516-13525
29. Li, M. X., Chandra, M., Pearlstone, J. R., Racher, K. I., Trigo-Gonzalez, G., Borgford, T., Kay, C. M., and Smillie, L. B. (1994) Biochemistry 33, 917-925
30. Spyracopoulos, L., Gagne, S. M., Li, M. X., and Sykes, B. D. (1998) Biochemistry 37, 18032-18044
31. Bingham, R. P. (1998) Structural and Functional Studies of the Troponin Complex from Human Cardiac Muscle. thesis , The University of Birmingham, Birmingham, U. K.
32. Francois, J.-M., Sedarous, S. S., and Gergely, J. (1997) J. Muscle Res. Cell Motil. 18, 323-334
33. Iio, T., and Kondo, H. (1981) J. Biochem. (Tokyo) 90, 163-175
34. Kometani, K., and Yamada, K. (1983) Biochim. Biophys. Res. Commun. 114, 162-167
35. Yamada, K. (1999) Mol. Cell. Biochem. 190, 39-45
36. Swenson, C. A., and Fredricksen, R. S. (1992) Biochemistry 31, 3420-3429
37. Pearlstone, J. R., and Smillie, L. B. (1995) Biochemistry 34, 6932-6940
38. Robertson, S. P., Johnson, D. J., and Potter, J. D. (1981) Biophys. J. 34, 559-569
39. Tripet, B., Van Eyke, J., and Hodges, R. S. (1997) J. Mol. Biol. 271, 728-750
40. Liao, R., Wang, C.-K., and Cheung, H. C. (1994) Biochemistry 33, 12729-12734
41. Wintrode, P. L., and Privalov, P. L. (1997) J. Mol. Biol. 266, 1050-1062
42. Tsvetkov, P. O., Protasevich, I. I., Gilli, P., Lafitte, D., Labachov, V. M., Haiech, J., Briand, C., and Makarov, A. A. (1999) J. Biol. Chem. 274, 18161-18164


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Biophys. JHome page
C. C. Lim, H. Yang, M. Yang, C.-K. Wang, J. Shi, E. A. Berg, D. R. Pimentel, J. K. Gwathmey, R. J. Hajjar, M. Helmes, et al.
A Novel Mutant Cardiac Troponin C Disrupts Molecular Motions Critical for Calcium Binding Affinity and Cardiomyocyte Contractility
Biophys. J., May 1, 2008; 94(9): 3577 - 3589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. L. Finley and P. R. Rosevear
Introduction of Negative Charge Mimicking Protein Kinase C Phosphorylation of Cardiac Troponin I: EFFECTS ON CARDIAC TROPONIN C
J. Biol. Chem., December 24, 2004; 279(52): 54833 - 54840.
[Abstract] [Full Text] [PDF]


This Article